Tag Archives: ABT

Top 5 Heal Care Stocks To Invest In 2018

Natural gas prices have been on the rise this year, and our natural gas price prediction for 2017 shows prices could surge by 36% in 2017.

Since hitting its 2016 low in March, the price of natural gas has rallied 121%.

The Henry Hub natural gas spot price today is $3.30 per million British thermal units (BTUs), compared to $1.90 in March.

The natural gas price chart below shows how much the market has rebounded in 2016:

And the dramatic upswing you’re seeing in natural gas prices is far from over.

That’s why we’re putting out our 2017 natural gas price prediction, to show you exactly what will be driving natural gas prices next year…

Why Are Natural Gas Prices So Volatile?

Like other commodities, supply and demand governs natural gas prices. But predicting demand can be complicated in the gas market.

Top 5 Heal Care Stocks To Invest In 2018: QuickLogic Corporation(QUIK)

Advisors’ Opinion:

  • [By Lisa Levin]

    QuickLogic Corporation (NASDAQ: QUIK) was down, falling around 10 percent to $2.10. QuickLogic reported a $15 million share offering.

    Commodities

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Lisa Levin]

    Thursday afternoon, the information technology sector proved to be a source of strength for the market. Leading the sector was strength from QuickLogic Corporation (NASDAQ: QUIK) and Veeco Instruments Inc. (NASDAQ: VECO).

Top 5 Heal Care Stocks To Invest In 2018: Formula Systems (1985) Ltd.(FORTY)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, technology shares fell by 0.32 percent. Meanwhile, top losers in the sector included Mitek Systems, Inc. (NASDAQ: MITK), down 13 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY), down 8 percent.

  • [By Lisa Levin]

    On Friday, technology shares rose by 0.26 percent. Meanwhile, top gainers in the sector included Applied Materials, Inc. (NASDAQ: AMAT), up 9 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY) up 19 percent.

Top 5 Heal Care Stocks To Invest In 2018: CVS Health Corporation(CVS)

Advisors’ Opinion:

  • [By Craig Jones]

    He also noticed a large options volume in CVS Health Corp (NYSE: CVS). Traders were buying the January 90 calls and they paid around $0.90 for them. The trade breaks even at $90.90 or around 15 percent higher from the closing price on Friday. Najarian also owns calls in CVS Health Corp.

  • [By Money Morning Staff Reports]

    Earlier this month, CVS Health Corp. (NYSE: CVS) announced its $69 billion plan to acquire Aetna Inc. (NYSE: AET), the third-largest health insurer in the United States. If successful, it will be the largest deal of the year – and the largest ever in health insurance history.

  • [By William Romov]

    Then, on the e-commerce front, National Vision sells its eyewear across 19 websites, including its own brands as well as Wal-Mart Stores Inc. (NYSE: WMT), Sam’s Club, and CVS Health Corp. (NYSE: CVS).

  • [By WWW.THESTREET.COM]

    Target (TGT) had missed projections for the last couple of quarters and didn’t have as strong growth online as some were looking for. Plus, when CVS (CVS) reported its miserable call, the stock got blasted because CVS said its drugstores in Target weren’t anything to write home about. So Target didn’t participate in the great retail rally that we had last week. Now it is front and center after that stronger-than-expected quarter. And make no mistake about it, that quarter was stronger than expected. (Disney and CVS are part of TheStreet’s Trifecta Stocks portfolio.)

Top 5 Heal Care Stocks To Invest In 2018: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Abbott Laboratories (ABT) , Dycom Industries (DY) and Howard Hughes (HHC) .

    Cramer was bearish on Headwaters (HW) , EnergySolutions (ES) , Western Refining (WNR) and Horizon Pharmaceuticals (HZNP) .

  • [By Matt Hogan]

    AbbVie has distributed a significant amount of its earnings in the form of dividends (~60 percent) since the company spun off from Abbott Laboratories (NYSE: ABT) in 2013. The company appears to be trading at a 10 percent discount to fair value when applying similar assumptions in the 5-year dividend discount model as shown below.

  • [By Sean Williams]

    Finally, and as the icing on the cake, Wall Street uncovered via a Securities and Exchange Commission filing that Abbott Laboratories (NYSE:ABT) sold 44 million shares of Mylan stock at $41.60, reducing its remaining position in the company to 25.75 million shares, or about 4.8% of its outstanding shares. Considering all the issues Mylan has had recently, the fact that Abbott substantially pared its large holding in the company is a bit worrisome.

Top 5 Heal Care Stocks To Invest In 2018: First Harvest Corp., Prior to Reverse Merger with Cannavoices, Inc. (HVST)

Advisors’ Opinion:

  • [By Javier Hasse]

    First Harvest Corp (OTC: HVST), acquired Cannavoices, Inc., a developer of cannabis-focused mobile games and social media platforms.

    "A trend we've seen developing slowly but steadily [is one] wherenew channels are being developed to reach cannabis consumers, primarily due to limits in advertising. There is so much regulation in the space that, in such an entrepreneurial environment where there are really no incumbent leaders, people are trying to be creative and figuring out ways to reach the cannabis consumer, both as an undeserved demographic and, just one that has still got that taboo around it, [leading] to larger players not necessarily getting involved yet." "Basically, they are trying to figure out ways to reach the consumer without direct TV advertising and stuff like that.”

    Related Link: Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High

stock market returns

The S&P 500 finished little changed–giving back all of today’s earlier gains in the process–but Michael Kors Holdings (KORS) held on to end the day as the S&P 500′s hottest stock.

Getty Images

Shares of Michael Kors gained 3.7% to $49.62 today, and the funny part is that there was no new news on the apparel & accessories retailer today. Nothing at all. I checked Dow Jones Newswires. I checked Google News. I checked Briefing.com. Nothing. Nada. Zilch. Bloomberg says Jefferies had a positive note, but the analyst tells me he didn’t write one. FactSet says Piper Jaffray wrote a note on Kors, which seems plausible since Piper’sErinn Murphy wrote a positive one onCoach (COH), another maker of handbags and other accessories, today, but I’ve yet to receive confirmation.

stock market returns: Universal Health Services, Inc.(UHS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Universal Health Services (UHS), yesterday’s biggest loser, soared to the top of the S&P 500 today as it rebounded from the massive selloff.

    Agence France-Presse/Getty Images

    Universal Health Servicesgained 6.9% to $108.57 today, while the S&P 500 rose 0.4% to 2,262.03.

    Weakness in Universal Health Services began when Buzzfeed ran an article last week, contending the companys psychiatric hospitals put profits ahead of people. Yesterday, it tumbled when Raymond James cut its rating on the stock due to problems that could be caused by a potential Senate investigation.

    Universal Health Services’ market capitalization rose to $10.5 today from $9.8 billion yesterday, nearly recouping its drop from $10.6 billion on Dec. 13.

    It reported net income of $680 million on sales of $9 billion in 2015.

  • [By Benzinga News Desk]

    Goldman Sachs (NYSE: GS) has at least one billion reasons to hope President Trump’s paring back of Dodd-Frank will include the Volcker Rule: Link

    ECONOMIC DATA
    10:30 a.m. Dallas Fed Manufacturing Business Index
    11:30 a.m. 6-Month Bill Auction
    11:30 a.m. 3-Month Bill Auction
    1 p.m. 2-Year Note Auction
    1:15 p.m. Chicago Fed President Evans Speaks
    6:30 p.m. FOMC Member Kaplan Speaks
    ANALYST RATINGS
    Piper Jaffray upgraded Best Buy Co (NYSE: BBY) from Neutral to Overweight
    Wells Fargo upgraded Allscripts Healthcare (NASDAQ: MDRX) from Market Perform to Outperform
    Mizuho upgraded Universal Health Service (NYSE: UHS) from Neutral to Buy
    Piper Jaffray downgraded The Michaels Companies (NASDAQ: MIK) from Overweight to Neutral
    JMP Securities downgraded KB Home (NYSE: KBH) from Market Outperform to Market Perform
    Raymond James downgraded Sierra Wireless Inc. (NASDAQ: SWIR) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Ben Levisohn]

    Universal Health Services (UHS) tumbled to the bottom of the S&P 500 today after BuzzFeed published an investigative story alleging that the company’s psychiatric hospitals put profits ahead of people.

    Getty Images

    Shares of Universal Health Services dropped 12% to$111.30 today, while the S&P 500 rose 1.3% to 2,241.35, a record high.

    Universal Health Services’ stock had been minding its business for most of the day–it was up 1.1% at $127.76 at 3:10 p.m. today–when the story by BuzzFeed’s Rosalind Adams went live. Here’s the gist:

    Millwood Hospital is part of Americas largest psychiatric hospital chain, Universal Health Services, or UHS. Its more than 200 psychiatric facilities across the country admitted nearly 450,000 patients last year. The result was almost $7.5 billion in revenues from inpatient care last year and profit margins of around 30%. More than a third of the companys overall revenue from both medical hospitals and psychiatric facilities comes from taxpayers through Medicare and Medicaid.

    A yearlong BuzzFeed News investigation based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents raises grave questions about the extent to which those profits were achieved at the expense of patients.

    Universal Health Services market capitalization dropped to $10.7 billion today from $12.3 billion yesterday. It reported net income of $680 million on sales of $9 billion in 2015.

  • [By David Zeiler]

    Fear that expense could return if Obamacare is repealed hammered hospital stocks on Nov. 9. HCA Holdings Inc. (NYSE: HCA) fell almost 11%. Universal Health Services Inc. (NYSE: UHS) slipped nearly 7%. And Tenet Healthcare Corp. (NYSE: THC) plummeted almost 25%.

  • [By Ben Levisohn]

    Universal Health Services (UHS) slumped to the bottom of the S&P 500 today after getting downgraded by Raymond James.

    Pixabay

    Universal Health Servicesdropped 6.8% to $101.55 today, while the S&P 500 fell 0.8% to 2,253.28.

    Raymond James analyst John Ransom and team explain why they cut Universal Health Services to Market Perform from Outperform:

    We are lowering our rating onUniversal Health Services to a Market Perform (from an Outperform) due to an escalation in events surrounding last weeks Buzzfeed article. Last Friday (12/9), Senator Grassley, Chair of the Judiciary Committee, sent a letter…to the office of inspector general regarding details of the current federal investigation into Universal Health Services. Specifically, the letter rehashes the Buzzfeed article and requests an update on the investigation by Dec. 23. Our view is that – even ifUniversal Health Services management is correct on the legalities – we think the entrance of the venerable Senator Grassley into the mix takes the political risk to a more dangerous level. Plus – even if “suicide ideation” doesn’t generate additional revenues per admission, we think it’s possible that the heightened political scrutiny could invite more caution and/or red tape into the admissions process – either externally or from self-policing. Add in the ongoing OIG investigation, and we think the risk-reward is no longer compelling.

    Universal Health Services’ market capitalization fell to $9.8 billion today from $10.6 billion yesterday. It reported net income of $680 million on sales of $9 billion in 2015.

  • [By Paul Ausick]

    Universal Health Services Inc. (NYSE: UHS) lost 8.4% Wednesday to post a new 52-week low of $1/99.81 after closing Tuesday at $108.99. The 52-week high is $139.77. Volume of around 5.8 million was nearly 6 times the daily average of around 1 million shares traded. Raymond James downgraded the stock this morning on news of another request for information from the company related to a federal investigation.

stock market returns: Progress Software Corporation(PRGS)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

  • [By Monica Gerson]

    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $93.15 million.

    Sorl Auto Parts, Inc. (NASDAQ: SORL) is expected to post its quarterly earnings at $0.20 per share on revenue of $55.35 million.

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects ConAgra Foods Inc (NYSE: CAG) to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion. ConAgra shares rose 0.17 percent to $47.68 in after-hours trading.
    Analysts expect Darden Restaurants, Inc. (NYSE: DRI) to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion. Darden Restaurants shares gained 0.44 percent to $66.25 in after-hours trading.
    Progress Software Corporation (NASDAQ: PRGS) reported better-than-expected results for its second quarter on Wednesday. Progress Software shares surged 6.19 percent to $26.75 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

stock market returns: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

stock market returns: Natus Medical Incorporated(BABY)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Elite Opportunity Pronewsletter suggested going long on small cap healthcare products and services stock Natus Medical (NASDAQ: BABY):

stock market returns: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Abbott Laboratories (ABT) , Dycom Industries (DY) and Howard Hughes (HHC) .

    Cramer was bearish on Headwaters (HW) , EnergySolutions (ES) , Western Refining (WNR) and Horizon Pharmaceuticals (HZNP) .

  • [By Matt Hogan]

    AbbVie has distributed a significant amount of its earnings in the form of dividends (~60 percent) since the company spun off from Abbott Laboratories (NYSE: ABT) in 2013. The company appears to be trading at a 10 percent discount to fair value when applying similar assumptions in the 5-year dividend discount model as shown below.

  • [By Sean Williams]

    Finally, and as the icing on the cake, Wall Street uncovered via a Securities and Exchange Commission filing that Abbott Laboratories (NYSE:ABT) sold 44 million shares of Mylan stock at $41.60, reducing its remaining position in the company to 25.75 million shares, or about 4.8% of its outstanding shares. Considering all the issues Mylan has had recently, the fact that Abbott substantially pared its large holding in the company is a bit worrisome.

Hot Medical Stocks To Own For 2018

Stocks will try to rebound from yesterday’s Fed-Ryan double whammy this morning after jobless claims fell more than expected.

Getty Images/iStockphoto

S&P 500 futures have advanced 0.1%, while Dow Jones Industrial Average futures have ticked up 0.1%. Nasdaq Composite futures have risen 0.1%.

Bed Bath & Beyond (BBBY) has climbed 3% to $38.95 after beating earnings forecasts.

Medtronic (MDT) has risen 1.9% to $81.75 on reports that Cardinal Health (CAH) will buy its medical supplies business.

Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

Constellation Brands (STZ) has rallied 4.7% to $169 after beating earnings forecasts and offering optimistic guidance.

Hot Medical Stocks To Own For 2018: Scripps Networks Interactive Inc(SNI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Discovery Communications Inc. (NASDAQ: DISCA) announced plans to acquire Scripps Networks Interactive, Inc. (NYSE: SNI) for $14.6 billion.

    Discovery will pay $90 per share in cash and stock to buy Scripps. The transaction is projected to close by early 2018.

  • [By Ben Levisohn]

    Scripps Networks Interactive (SNI) sunk to the bottom of the S&P 500–narrowly beating out Apartment Investment and Management (AIV)–as the parent company of the Food Network and other channels gave back a chunk of its post-elections gains.

    Getty Images

    Shares of Scripps Networks Interactive dropped 4.2% to $70.63 today, while the S&P 500 rose 0.8% to 2,180.39. Scripps had gained 13% from Nov. 8 through Nov. 14.

    Scripps reported net income of $607 million on sales of $3 billion in 2015.

    Barron’s David Englander recommended Scipps Networks’ former parent E.W. Scripps (SSP) back in August.

     

     

Hot Medical Stocks To Own For 2018: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By Matt Hogan]

    AbbVie has distributed a significant amount of its earnings in the form of dividends (~60 percent) since the company spun off from Abbott Laboratories (NYSE: ABT) in 2013. The company appears to be trading at a 10 percent discount to fair value when applying similar assumptions in the 5-year dividend discount model as shown below.

  • [By Sean Williams]

    Finally, and as the icing on the cake, Wall Street uncovered via a Securities and Exchange Commission filing that Abbott Laboratories (NYSE:ABT) sold 44 million shares of Mylan stock at $41.60, reducing its remaining position in the company to 25.75 million shares, or about 4.8% of its outstanding shares. Considering all the issues Mylan has had recently, the fact that Abbott substantially pared its large holding in the company is a bit worrisome.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Abbott Laboratories (ABT) , Dycom Industries (DY) and Howard Hughes (HHC) .

    Cramer was bearish on Headwaters (HW) , EnergySolutions (ES) , Western Refining (WNR) and Horizon Pharmaceuticals (HZNP) .

Hot Medical Stocks To Own For 2018: CenturyLink, Inc.(CTL)

Advisors’ Opinion:

  • [By Paul Ausick]

    CenturyLink Inc. (NYSE: CTL) dropped about 3.4% Tuesday to post a new 52-week low of $13.16 after closing at $13.62 on Monday. The 52-week high is $27.61. Volume was around 14 million, less than 10% above the daily average of around 13 million. The telecom company had no specific news.

  • [By Paul Ausick]

    CenturyLink Inc. (NYSE: CTL) dropped about 7.8% Monday to post a new 52-week low of $17.07 after closing at $18.51 on Friday. The 52-week high is $30.39. Volume was around 21 million, about double the daily average of around 11 million. The company’s $34 billion acquisition of Level 3 Communications received FCC approval, but the company was hit with a charge of securities fraud.

  • [By WWW.MONEYSHOW.COM]

    Originally a rural telecom, CenturyLink (CTL) has grown via acquisitions to become a major provider of broadband, voice, video, and data.

    It now provides services residential and business customers over a 250,000-route-mile US fiber network and a 300,000 mile international network.

  • [By Ben Levisohn]

    Very strong results across the board for Dycom, with spending from its top customers only further accelerating. We’re not surprised that FQ3 guidance came in slightly ahead of expectations, as many investors had viewed their initial guidance as conservative. We are encouraged to see organic growth re-accelerating in FQ4 to the mid-teens, with its acquired Goodman asset contributing $15MM of expected revenue (up from $13.4MM in FQ2). Dycom also procured new customer awards in the quarter from AT&T (T), Comcast (CMCSA), CenturyLink (CTL) and Windstream Holdings (WIN) to support further growth. Dycom also repurchased $25MM of shares during FQ2 and authorized an additional $75MM over the next 18 months, giving Dycom $150MM of incremental repurchase authorization through August 2018

  • [By Paul Ausick]

    CenturyLink Inc. (NYSE: CTL) posted a new 52-week low of $21.62 on Thursday, down about 8.9% from Wednesday’s closing price of $23.74. The stock’s 52-week high is $33.45. Volume totaled around 20 million shares, double the daily average of around 10 million. The telecom firm missed expectations this morning and lowered guidance — a potent one-two punch to the stock price.

  • [By Paul Ausick]

    CenturyLink Ink. (NYSE: CTL) dropped about 8.3% Wednesday to post a new 52-week low of $14.06 after closing at $15.33 on Tuesday. The stock’s 52-week high is $27.61. Volume of around 14 million was less than 10% above the daily average. The telecom company declared a quarterly dividend of $0.54 per share payable next month. The dividend yield on the stock is now over 14%, a level that always makes investors nervous. Shares are on track to close the day up nearly 3% on the dividend announcement.

Hot Medical Stocks To Own For 2018: Talisman Energy Inc.(TLM)

Advisors’ Opinion:

  • [By Jayson Derrick]

    On the other hand, the analysts are Underweight on Eni SpA (ADR) (NYSE: E), Repsol Oil & Gas Canada Inc (USA) (NYSE: TLM) and OMV AG given their asset bases, which offer an inferior risk to reward profile and limited differentiation in cost reductions.

Hot Medical Stocks To Own For 2018: TeleNav Inc.(TNAV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Telenav Inc (NASDAQ: TNAV) shares were also up, gaining 16 percent to $8.15 after the company reported the settlement of patent lawsuit. The company projects Q2 revenue of $51 million to $52 million and loss of $0.30 per share to $0.28 per share.

Hot Medical Stocks To Own For 2018: Graham Corporation(GHM)

Advisors’ Opinion:

  • [By Monica Gerson]

    Graham Corporation (NYSE: GHM) is expected to report its quarterly earnings at $0.12 per share on revenue of $23.54 million.

    Heico Corp (NYSE: HEI) is estimated to post its quarterly earnings at $0.54 per share.

12 Best Dividend Stocks for the Next 12 Months

Finding the best dividend stocks involves looking beyond the next few weeks and thinking about a long-term investment. After all, if you’re only in a dividend stock for a short time then you may not get the full yield that’s based on a full year of payouts.

And heck, if you don’t pay attention to dividend dates, you may not get a single payment!

It’s much better, then, to focus on the best dividend stocks for the next year instead of just the next month. That is the only way to ensure that you get a full battery of payments from your investments, and that you maximize the income potential of your portfolio.

In truth, all investors are too short-sighted with their portfolios. They fear short-term volatility, and make rash decisions. But particularly if you’re a dividend investor, thinking in any less than 12-month increments can be very detrimental to your performance.

To help you make the most of 2018, then, here are 12 dividend stocks that will continue to profit for the next 12 months, not just the short term.

Dividend Stocks to Buy Now: Enterprise Products Partners (EPD) Dividend Stocks to Buy Now - Enterprise Products Partners (EPD)investorplace.com/wp-content/uploads/2016/05/epdmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/epdmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/epdmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/epdmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/epdmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/epdmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/epdmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/epdmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/05/epdmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Bilfinger via Flickr
Sector: Energy Market Cap: $52 billion Yield: 7% YTD Return: -10% vs. 17% for the S&P 500

Pipeline operator Enterprise Products Partners L.P. (NYSE:EPD) is a great example of the income potential in energy stocks. While exploration and production companies have to take on big debts on the hopes that they will strike enough oil to turn a profit, EPD is just a middleman between those producers and the marketplace. That insulates it from the volatility of energy prices, and allows for a more reliable revenue stream.

In addition to the reliable revenue stream of its business, EPD also boasts an impressive scale that should be attractive to low-risk investors. The energy company operates more than 49,000 miles of pipeline, 260 million barrels of crude oil storage and another 14 billion cubic feet of natural gas storage.

Currently, Enterprise Products offers a great yield of 7%, and has a strong track record of raising distributions over time, too. It’s this constant and growing payout that is the hallmark of a good MLP investment.

Dividend Stocks to Buy Now: Ladder Capital (LADR) Dividend Stocks to Buy Now: Ladder Capital (LADR)investorplace.com/wp-content/uploads/2016/09/reitmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/09/reitmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/09/reitmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/09/reitmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/09/reitmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/09/reitmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/09/reitmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/09/reitmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/09/reitmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Yuriy Trubitsyn via Unsplash
Sector: REITs Market Cap: $2 billion Yield: 9.2% YTD Return: 1% vs. 17% for the S&P 500

Ladder Capital Corp (NYSE:LADR) is not your typical real estate investment trust. Unlike other stocks that own shopping malls or office parks, LADR doesn’t own physical properties. Instead, it invests as a third party in these real estate holdings either through lending, equity investments or other financing.

This makes Ladder Capital more of a financial stock than a real estate play in a way, since its stock is tied to the performance of its underlying investments in properties. But the difference is that while banks can operate with a bit more flexibility, the designation as an REIT demands that the firm delivers 90% of taxable income back to shareholders. That is a mandate for big dividends, with LADR being a pass-through for shareholders who want to share in the fruits of its investments.

Those investments are looking pretty strong, too, with loans and investment in properties that span the country from New York to L.A. Those deals collectively deliver a more than 9% dividend to shareholders via the interest on those loans and other capital appreciation. And as the American economy continues to thrive with low unemployment, high consumer confidence and a roaring stock market, these investments are sure to keep delivering.

This is a great cyclical dividend play for the next few years as a result of rising rents and property values in 2018.

Dividend Stocks to Buy Now: AbbVie (ABBV) Dividend Stocks to Buy Now: AbbVie (ABBV)investorplace.com/wp-content/uploads/2016/04/abbvmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2016/04/abbvmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/04/abbvmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Black Stripe via Wikimedia (Modified)
Sector: Healthcare Market Cap: $153 billion Yield: 3% YTD Return: 52% vs. 17% for the S&P 500

AbbVie Inc (NYSE:ABBV) was spun off of Big Pharma mainstay Abbott Laboratories (NYSE:ABT) in 2013, and it is the drug-focused arm of the previous company. It’s home to current blockbusters, including psoriasis treatment Humira as well as a research-driven drugmaker looking for the next generation of big-name cures.

Analysts are projecting revenue growth at ABBV of almost 10% this year and next, and profit expansion of 15% or better both years thanks to a strong pharmaceutical portfolio. And that success has translated into generous dividends, as the company has ramped up its payout from 40 cents after its initial spin-off to 64-cents-per-share just four years later.

With decent profit growth resulting in continued dividend growth, investors can enjoy not just a robust payout now, but the hopes of continued payouts from this healthcare giant going forward.

Dividend Stocks to Buy Now: Southern Company (SO) Dividend Stocks to Buy Now: Southern Company (SO)investorplace.com/wp-content/uploads/2016/04/somsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/somsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/somsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/somsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/somsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/somsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/somsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/somsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/04/somsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2016/04/somsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/somsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/04/somsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Desiree Kane via Flickr
Sector: Utilities Market Cap: $51 billion Yield: 4.5% YTD Return: 4% vs. 17% for the S&P 500

Southern Co (NYSE:SO) is one of the largest utilities in the U.S., serving 19 states through various subsidiaries. While its oldest core holdings, including Alabama Power and Georgia Power, are electric utilities, the company’s Southern Company Gas operates a massive natural gas distribution business from Maryland to Florida and its Southern Telecom is a play on fiber optics in the Southeast as well.

SO stock offers scale and stability, and is a consistent dividend payer that has mailed check to shareholders since 1982. On top of that, Southern Company has raised dividend payouts at least once each year since 2001 even as it has continued to expand aggressively into other businesses and geographies.

Utility stocks are some of the safest bets out there thanks to geographic monopolies and a highly regulated industry that doesn’t allow for new entrants or much competition. As one of the nation’s leading utilities with a reliable customer base, SO is sure to prosper in 2018.

Dividend Stocks to Buy Now: Phillips 66 Partners (PSXP) Dividend Stocks to Buy Now – Phillips 66 Partners (PSXP)investorplace.com/wp-content/uploads/2017/05/oilmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/oilmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/oilmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/oilmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/oilmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/oilmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/oilmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/oilmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/05/oilmsn-170×93.jpg170w, investorplace.com/wp-content/uploads/2017/05/oilmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: Energy Market Cap: $5 billion Yield: 5.8% YTD Return: -7% vs. 17% for the S&P 500

Many of the most successful MLPs have been created by large energy companies that want the benefit from the unique structure of this kind of business. It’s often a win-win for both the primary stock that is the general partner as well as for the new partnership that has been created, and that’s exactly the case with Phillips 66 Partners LP (NYSE:PSXP) and its corporate parent ConocoPhillips (NYSE:COP).

Spun off in 2013, Phillips 66 Partners consists of pipelines, terminals and other midstream assets that help power the broader ConocoPhillips business. The tax benefits and a generous yield of over 5% kicked back to COP as a major investor make it great for the parent, but the MLP benefits nicely too. Consider PSXP received more than $2.3 billion in projects from its parent company last year alone!

Phillips 66 Partners has raised its distribution for 16 consecutive quarters since entering public markets, and is clearly committed to delivering consistent income to its shareholders.

Dividend Stocks to Buy Now: Medical Properties Trust (MPW) Dividend Stocks to Buy Now – Medical Properties Trust (MPW)investorplace.com/wp-content/uploads/2017/09/mpwmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-170×93.jpg170w, investorplace.com/wp-content/uploads/2017/09/mpwmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: REITs Market Cap: $5 billion Yield: 7% YTD Return: 12% vs. 17% for the S&P 500

Medical Properties Trust, Inc. (NYSE:MPW) is a fast-growing REIT seeing brisk expansion of its funds from operations — the most important measure we can get from this special class of tax-sheltered companies. That reliable and growing flow of cash also helps fuel reliable and growing dividends, to the tune of 7% currently.

But it’s not just the income potential that’s worth a look here. Aging baby boomers are increasing demand for care in the U.S., inflationary trends guarantee pricing power in the sector, and even in an economic downturn you’ll see Americans cut back on everything but their healthcare.

MPW is well-positioned to capitalize on this trend thanks to its ownership of community hospitals and acute-care centers — and a recent acquisition of 11 more facilities will certainly boost its numbers in the year ahead.

Dividend Stocks to Buy Now: Altria (MO) Dividend Stocks to Buy Now: Altria (MO)investorplace.com/wp-content/uploads/2016/05/momsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/momsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/momsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/momsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/momsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/momsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/momsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/momsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/05/momsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Peyri Herrera via Flickr (Modified)
Sector: Consumer staples Market Cap: $129 billion Yield: 3.9% YTD Return: -2% vs. 17% for the S&P 500

Altria Group Inc (NYSE:MO) may strike some as a no-growth company without much upside. However, this pick is not just a dividend stock; consider that over the past five years, it has actually outperformed the S&P 500 in share price performance alone thanks to aggressive buybacks and shrewd management of profitability.

And of course, MO stock is a go-to for dividend investors after 48 consecutive years of increases in its payout. Those increases aren’t a penny here and there, either — as evidenced most recently with an 8% bump in 2017 from 61 cents to 66 cents.

Yes, traditional tobacco products are on the outs. But keep in mind that Altria is not merely Philip Morris USA — the name behind iconic cigarette brands like Marlboro and Parliament. Altria also dabbles in smokeless products and even wines via producer Ste. Michelle. This provides an added level of long-term stability.

Shares haven’t done much lately in 2017, but with a forward price-to-earnings ratio of less than 18 and reliable profit growth ahead in 2018, I’d bank on Altria regardless of short-term market trends.

Dividend Stocks to Buy Now: Cisco (CSCO) Dividend Stocks to Buy Now: Cisco (CSCO)investorplace.com/wp-content/uploads/2017/05/cscomsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/cscomsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/cscomsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/cscomsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/cscomsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/cscomsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/cscomsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/cscomsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/05/cscomsn-170×93.jpg 170w,https://investorplace.com/wp-content/uploads/2017/05/cscomsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: Technology Market Cap: $186 billion Yield: 3.1% YTD Return: 25% vs. 17% for the S&P 500

When investors look for reliable dividend stocks, often they overlook the tech sector. That’s in part because even tech companies like Apple Inc. (NASDAQ:AAPL) that pay some kind of dividend still offer less than 10-year Treasuries — or on the flip side, because many tech stocks that do yield a decent amount don’t have much to offer investors beyond their dividends.

But Cisco Systems, Inc. (NASDAQ:CSCO) stands apart. Not only does the IT giant currently offer an attractive dividend, with payouts that have jumped from 6 cents in 2011 to 29 cents a quarter at present, it also has a good growth story to tell after an impressive earnings report before Thanksgiving. Not only did it beat on earnings and boost its outlook, but the company showed Wall Street it is effectively transitioning away from networking hardware and into cloud-based solutions that are the norm in 2017. Shares are up about 20% in the last three months as a result.

These structural improvements at CSCO bode well for 2018 and beyond. And given Cisco’s commitment to increased dividends and deep pockets with some $72 billion in cash and investments in the bank, you can be certain this company will keep rewarding shareholders for the next decade to come.

Dividend Stocks to Buy Now: Diageo (DEO) Dividend Stocks to Buy Now: Diageo (DEO)investorplace.com/wp-content/uploads/2016/05/deomsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/deomsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/deomsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/deomsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/deomsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/deomsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/deomsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/deomsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/05/deomsn.jpg 728w” sizes=”(max-width: 300px)100vw, 300px” />Source: Puamella via Flickr (Modified)
Sector: Consumer staples Market Cap: $87 billion Yield: 2.3% YTD Return: 35% vs. 17% for the S&P 500

Diageo plc (ADR) (NYSE:DEO) is a world leader in the spirits business, with mega-brands including Johnnie Walker whisky, Smirnoff vodka, Tanqueray and Guinness beer, among a host of others. And thanks to a focus mainly on liquor, DEO stock has been largely insulated from the shakeup we’ve seen in the beer biz as craft brews have eroded share.

For instance, even as Anheuser Busch InBev NV (ADR) (NYSE:BUD) has struggled since 2015 despite a $200 billion operation with some of the biggest mainline beers on the planet, Diageo has slightly outperformed the market thanks to modest but consistent growth.

As a “sin stock,” Diageo also has the unique benefit of seeing stable or even increased demand during hard times. After all, why give up your cocktails if the market is crashing, hurricanes are bearing down on your house and North Korea is thinking of detonating a nuke?

Dividend Stocks to Buy Now: Dominion Energy (D) Dividend Stocks to Buy Now: Dominion Energy (D)investorplace.com/wp-content/uploads/2016/12/energy-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/12/energy-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/12/energy-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/12/energy-400×220.jpg 400w, investorplace.com/wp-content/uploads/2016/12/energy-116×64.jpg 116w, investorplace.com/wp-content/uploads/2016/12/energy-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/12/energy-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/12/energy-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/12/energy-170×93.jpg 170w,https://investorplace.com/wp-content/uploads/2016/12/energy.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Riccardo Annandale Via Unsplash
Sector: Utilities Market Cap: $52 billion Yield: 3.7% YTD Return: -10% vs. 17% for the S&P 500

Dominion Energy Inc (NYSE:D) is a safe play for a host of reasons. But chief among them are the facts that it is a low-risk utility stock with reliable operations and a significant yield.

Dominion generates electricity mainly in the mid-Atlantic region of the U.S. from North Carolina to Pennsylvania and distributes natural gas across a wide swath of the American West. The consistent cash flow from these operations has fueled consistent dividend payouts for almost 90 years, and has allowed Dominion to grow payouts substantially over time; distributions were 39.5 cents quarter at the end of 2008 and are now 77 cents, an increase of about 95% in about nine years.

The icing on the cake is that Dominion is one of the most adaptable and diversified utilities in the U.S., with numerous nuclear and renewable power generation facilities in its portfolio. This isn’t just good as a hedge against the long-term decline of fossil fuels, but also a bridge to new business. One recent headline that should really pique investor interest is a recent contract to provide renewable energy to a Facebook Inc (NASDAQ:FB) data center in Virginia.

That kind of willingness to meet big corporations where they live is a strong sign that Dominion is forward-thinking and isn’t just sitting back collecting monthly checks from customers.

Dividend Stocks to Buy Now: Merck (MRK) Dividend Stocks to Buy Now: Merck (MRK)investorplace.com/wp-content/uploads/2017/10/mrkmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-170×93.jpg 170w,https://investorplace.com/wp-content/uploads/2017/10/mrkmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: Healthcare Market Cap: $151 billion Yield: 3.4% YTD Return: -6% vs. 17% for the S&P 500

Merck & Co., Inc. (NYSE:MRK) continues to see growth as its drugs look to fight common American health conditions. Its blockbuster diabetes drug Januvia, which helps lower blood sugar, accounts for some $4 billion in annual sales and its Zetia cholesterol medication racks up over $2 billion in annual sales.

And it’s not done, either, with a strong product pipeline that includes cancer drug Keytruda. The pipeline could open avenues to much bigger revenue after a very nice showing so far in 2017. The marriage of so-called “maintenance” drugs to provide regular revenue will fuel dividends now, and new drugs could yield continued dividend growth going forward.

With one of the biggest and most stable brands in medicine, this healthcare stock is a great long-term play for dividend investors. The healthcare company has paid consistent dividends since 1970, and is a rock-solid bet for the coming year.

Dividend Stocks to Buy Now: Procter & Gamble (PG) Why PG Stock Quietly Became a Buyinvestorplace.com/wp-content/uploads/2016/04/pgmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/pgmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/pgmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/pgmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/pgmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/pgmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/pgmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/pgmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/04/pgmsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2016/04/pgmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/pgmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/04/pgmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Mike Mozart via Flickr (Modified)
Sector: Consumer staples Market Cap: $1225 billion Yield: 3.1% YTD Return: 6% vs. 17% for the S&P 500

You couldn’t have a list of safe-haven investments without Procter & Gamble Co (NYSE:PG), one of the most reliable consumer names on the planet.

Powered by amazing brands from Dawn dish soap to Gillette shaving products to Crest toothpaste, P&G has its fingerprints all over the typical household. And best of all for low-risk investors, these products will keep selling no matter what the macro picture is like because people still need to clean their bodies and their kitchens regardless of where the S&P is headed.

It also has a consistent commitment to dividends, increasing its payout for the last 60 straight years, and has been generous with those increases to boot; distributions have roughly doubled in the last decade, meaning P&G dividend hikes are in the ballpark of 10% each year.

Yes, shares have been rangebound for a few years now. But a recent proxy fight with activist investor Nelson Peltz has shaken the company awake. And even if the tally in the voting has been disputed by P&G, the message from its investors is crystal clear: pay more attention to the bottom line and to delivering real shareholder value. That should usher in some important changes that help this stock remain dominant as we enter 2018.

As of this writing, Jeff Reeves did not have a position in any of the aforemen

Top 10 Blue Chip Stocks To Own Right Now

During these busy times, it pays to stay on top of the latest profit opportunities, and today’s blog post is a great place to start.

After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 113 big blue chips.

Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

This Week’s Ratings Changes:

Top 10 Blue Chip Stocks To Own Right Now: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By Matt Hogan]

    AbbVie has distributed a significant amount of its earnings in the form of dividends (~60 percent) since the company spun off from Abbott Laboratories (NYSE: ABT) in 2013. The company appears to be trading at a 10 percent discount to fair value when applying similar assumptions in the 5-year dividend discount model as shown below.

  • [By Sean Williams]

    Finally, and as the icing on the cake, Wall Street uncovered via a Securities and Exchange Commission filing that Abbott Laboratories (NYSE:ABT) sold 44 million shares of Mylan stock at $41.60, reducing its remaining position in the company to 25.75 million shares, or about 4.8% of its outstanding shares. Considering all the issues Mylan has had recently, the fact that Abbott substantially pared its large holding in the company is a bit worrisome.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Abbott Laboratories (ABT) , Dycom Industries (DY) and Howard Hughes (HHC) .

    Cramer was bearish on Headwaters (HW) , EnergySolutions (ES) , Western Refining (WNR) and Horizon Pharmaceuticals (HZNP) .

Top 10 Blue Chip Stocks To Own Right Now: Allied World Assurance Company Holdings, AG(AWH)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    The insurance firms of Allied World Assurance Company Hldgs Ltd (NYSE: AWH) and Fairfax Financial extended the offering period for purchase of outstanding Allied World shares from June 30 to July 5.

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Friday.

    Douglas Dynamics Inc (NYSE: PLOW) – $0.2350 dividend, 2.9183 percent yield
    Tiffany & Co. (NYSE: TIF) – $0.4500 dividend, 2.6758 percent yield
    PulteGroup, Inc. (NYSE: PHM) – $0.0900 dividend, 1.7078 percent yield
    Leidos Holdings, Inc. (NYSE: LDOS) – $0.3200 dividend, 3.0851 percent yield
    Tupperware Brands Corporation (NYSE: TUP) – $0.6800 dividend, 4.1756 percent yield
    Hudson Pacific Properties Inc (NYSE: HPP) – $0.2000 dividend, 2.36

Top 10 Blue Chip Stocks To Own Right Now: FMC Corporation(FMC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

  • [By WWW.THESTREET.COM]

    With an improving global economy, now is a great time to be a chemical company, Cramer told viewers, as he reiterated his favorites: Albemarle (ALB) and FMC Technology  (FMC) .

Top 10 Blue Chip Stocks To Own Right Now: iShares MSCI All Peru Capped ETF (EPU)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    ARGT, the lone exchange traded fund dedicated to Argentine equities, is up 19.6 percent year-to-date. That is good for the second-best showing among Latin America single-country ETFs, trailing only the iShares MSCI Capped Peru Index Fund (NYSE: EPU).

  • [By Andrew Efimoff] Related Some Positive Indexing News For A Frontier Markets ETF Why The Frontier Markets ETF Slumped Last Year Status Quo Decisions Would Bode Well For PAK ETF (Seeking Alpha)
    Related EPU Peru ETF Confronts Politics Commodities Call For The Colombia ETF Gra帽a Y Montero May Have Peaked In 2016 (Seeking Alpha) Gainers Pakistan: Global XMSCI Pakistan ETF (NYSE: PAK) is up 5.67 percent after receiving MSCI’s Emerging Markets Index approval. Peru: iShares MSCI All Peru Capped Index Fund(NYSE: EPU) is up 2.15 percent after Kuzynski won Peru’s nail-biting election. Philippines: iShares MSCI Philippines Investable(NYSE: EPHE) is up 2.21 percent after Macquarie Research said President Elect Rodrigo Duterte would lift the Pilipino property market. India: iShares MSCI India ETF (NYSE: INDA) is up 1.96 percent after India’s government relaxed regulation, making it easier for domestic airlines to fly overseas.

    Related Link: Some Positive Indexing News For A Frontier Markets ETF

Top 10 Blue Chip Stocks To Own Right Now: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap high-performance wireless infrastructure solutions stock Westell Technologies (NASDAQ: WSTL) as a buy for our short-term portfolio:

Top 10 Blue Chip Stocks To Own Right Now: BioAmber Inc.(BIOA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Bioamber Inc (NYSE: BIOA) shares dropped 19 percent to $2.55. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

  • [By Paul Ausick]

    BioAmber Inc. (NYSE: BIOA) dropped nearly 29% Friday to post a new 52-week low of $2.24 after closing Thursday at $3.14. Volume of more than 1.5 million shares was about 6 times the daily average of around 240,000. The company’s annual report, filed on Thursday with its quarterly results, included a “going concern” statement from the company’s independent auditing firm.

  • [By Markus Aarnio]

    BioAmber (BIOA) is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products.

Top 10 Blue Chip Stocks To Own Right Now: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Lee Jackson]

    Aco-chief executive officer of American Financial Group Inc. (NYSE: AFG), Carl Linder, sold a total of 200,000 shares of the property and casualty insurance products provider at prices that ranged from $90.63 to $91.62. The total for the sale was set at $18 million. The shares closed Friday at $91.55, in a52-week range of $65.38 to $92.38. The consensus price target is $95.50.

Top 10 Blue Chip Stocks To Own Right Now: Insperity, Inc.(NSP)

Advisors’ Opinion:

  • [By Lee Jackson]

    Insperity Inc. (NYSE: NSP) also had a large-scale seller on the desk, and it was another well-known hedge fund. Value Act, which also serves as a director at the company, sold a total of 226,000 shares of the stock at prices that ranged from $71.22 to $72.41. The total for the sale was set at $16 million.Insperity provides an array of human resources and business solutions to enhance business performance for small and medium-sized businesses in the United States. The shares closed the day on Friday at $71.85.

Top 10 Blue Chip Stocks To Own Right Now: Xenon Pharmaceuticals Inc.(XENE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 53 percent to $4.68 after the company disclosed that XEN801 did not meet efficacy endpoints in Phase 2 trial.

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggestedgoing long on small cap orphan biopharmaceutical stock Xenon Pharmaceuticals (NASDAQ: XENE):

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested going long on small cap biopharmaceutical stock Xenon Pharmaceuticals Inc (NASDAQ: XENE):

  • [By Lisa Levin]

    Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 51 percent to $4.80 after the company disclosed that XEN801 did not meet efficacy endpoints in Phase 2 trial.

Top 10 Blue Chip Stocks To Own Right Now: Intercontinental Exchange Inc.(ICE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Altria (MO) , Intercontinental Exchange (ICE) and Micron Technology (MU) .

    Cramer was bearish on NVIDIA (NVDA) and Reynolds American (RAI) .